bevacizumab-vikg

FDA Drug Profile — LYTENAVA

bevacizumab-vikg is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including LYTENAVA. Available dosage form: injection.

Drug details

Generic Name
bevacizumab-vikg
Brand Names
LYTENAVA
Application Number
BLA761320
Sponsor
Outlook Therapeutics, Inc.
NDC Codes
3
Dosage Forms
INJECTION
Routes
INTRAVITREAL
Active Ingredients
BEVACIZUMAB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.